Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.

A new twist on two-photon polymerization has been used to deliver objects, including lasers and an elephant, directly into ...

To date, the Endangered Species Act has been the country’s key weapon in the fight against extinction. While the law’s protection mechanisms have helped rescue nearly 300 species from going the way of ...

Bioengineering is revolutionizing cancer research. This area of science integrates engineering and physical sciences with oncology to change how we understand and treat this complex disease.

India's IIT Hyderabad, in partnership with Germany's Institute for Lung Health, launched a first-of-its-kind Bioengineering ...

At an event dedicating the Omenn-Darling Bioengineering Institute, Princeton University emphasized its commitment to innovative research in the life sciences and engineering, informed by collaboration ...

Bioengineering has the power to improve global health by developing tools that function in resource-constrained contexts. This collection brings together articles discussing access-conscious and ...

This article is the part of a series of student spotlights featuring students from a variety of academic departments at Stanford and the highlights and challenges of their academic journey. When ...

When he was 10 years old, Joseph Connell was burned on 30% of his body. His leg was so severely damaged the wound went down to the bone, and doctors told him he would never walk again. Connell had 360 ...

Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the first National Cancer Institute-designated ...

Bioengineering aims to improve targeted cancer therapies by enhancing drug delivery, boosting immune responses, and refining surgical techniques. The field is highly interdisciplinary, merging ...

David Magnus Ph.D. ’89 is the director of the Stanford Center for Biomedical Ethics and the Co-chair of the Ethics Committee for the Stanford Hospital. The Stanford Center for Biomedical Ethics ...